Further GSEA using transcriptional analysis revealed that the two HER2 (+) breast cancer cell lines have different resistance mechanisms after long-term exposure to lapatinib; estrogen response-related genes are major mechanisms in BT474 cells. This evidence concerns the gene ERBB2 and breast carcinoma.